Triptorelin – July 2026

  • Intramuscular (I.M.) injection 3.75 mg with solvent, syringe and needles

  • Brand names:
    • Diphereline®
  • Pharmaceutical Company:
    • IPSEN PTY LTD
  • Condition/Indication: Treatment with gonadotrophin releasing hormone (GnRH) agonist
  • Meeting Date: July 2026

Last updated
12 November 2026